Published in Chest on June 01, 2010
Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients. AIDS (2012) 0.93
Smoking and HIV: time for a change? BMC Med (2013) 0.87
Protein trafficking dysfunctions: Role in the pathogenesis of pulmonary arterial hypertension. Pulm Circ (2011) 0.83
Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension. Mol Med (2015) 0.76
Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus-Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia. Am J Respir Cell Mol Biol (2015) 0.75
Isolated right ventricular dysfunction in patients with human immunodeficiency virus. J Card Fail (2014) 0.75
Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med (2006) 6.06
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med (1994) 5.22
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83
Inflammation in pulmonary arterial hypertension. Eur Respir J (2003) 3.18
Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med (2003) 3.00
HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic (2010) 2.47
Primary pulmonary hypertension in HIV infection. Chest (1991) 2.40
Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev (2006) 2.25
Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS (2008) 2.12
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med (2007) 2.03
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis (2004) 1.89
HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med (2006) 1.58
Electron microscopy of the plexiform lesion. Thorax (1979) 1.55
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J (1998) 1.51
Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 1.46
HIV-Related pulmonary hypertension: analytic review of 131 cases. Chest (2000) 1.45
HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol (2005) 1.45
Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol (2004) 1.39
p21-activated kinase 1 plays a critical role in cellular activation by Nef. Mol Cell Biol (2000) 1.35
HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol (2003) 1.30
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation (2005) 1.29
HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS (2010) 1.27
Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med (2008) 1.27
Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis (1992) 1.23
Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion. J Leukoc Biol (2008) 1.20
Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management. Am J Hematol (2008) 1.16
Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era. AIDS (2008) 1.13
HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis (2002) 1.07
Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol (2009) 1.05
SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques. Virology (1999) 1.02
Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J Virol (2005) 1.02
Primary pulmonary hypertension in HIV patients: a systematic review. Angiology (2001) 0.97
Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2007) 0.96
Evidence for vascular remodeling in the lungs of macaques infected with simian immunodeficiency virus/HIV NEF recombinant virus. Chest (2005) 0.96
Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study. HIV Med (2008) 0.96
HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res (2009) 0.96
HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. J Leukoc Biol (2005) 0.91
Extracellular HIV-1 Nef increases migration of monocytes. Exp Cell Res (2006) 0.88
Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem Biophys Res Commun (2000) 0.87
HIV-related pulmonary hypertension. From pathogenesis to clinical aspects. Acta Cardiol (2004) 0.87
Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France. AIDS (2005) 0.87
Pulmonary arterial hypertension and its association with HIV infection: an overview. AIDS (2008) 0.85
HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. Regul Pept (1998) 0.83
Mediators involved in HIV-related pulmonary arterial hypertension. AIDS (2008) 0.81
Pulmonary hypertension in individuals with HIV infection. AIDS (2006) 0.81
Pulmonary arterial hypertension and HIV infection. AIDS (2008) 0.78
Prosthetic joint infection: recent developments in diagnosis and management. J Infect (2010) 4.96
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis (2004) 4.26
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis (2013) 4.06
Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol (2009) 3.75
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol (2003) 2.59
Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem (2005) 1.88
Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med (2003) 1.85
A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes (2002) 1.75
Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe (2013) 1.66
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3. Am J Physiol Lung Cell Mol Physiol (2003) 1.66
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.64
Surgical site infection - a European perspective of incidence and economic burden. Int Wound J (2004) 1.61
HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med (2006) 1.58
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One (2008) 1.56
Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting. Eur J Epidemiol (2004) 1.50
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. Clin Infect Dis (2014) 1.47
Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects. Am J Respir Crit Care Med (2015) 1.44
Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol (2008) 1.38
High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: comparison with chronic stable angina and normal controls. Heart (2010) 1.37
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob (2009) 1.24
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother (2010) 1.23
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother (2011) 1.18
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study. J Infect Dis (2002) 1.15
Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3. J Antimicrob Chemother (2013) 1.15
A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med (2009) 1.13
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections. Expert Rev Anti Infect Ther (2013) 1.13
Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants. Hepatology (2004) 1.12
Rhodococcus equi infection in HIV-infected individuals: case reports and review of the literature. AIDS Patient Care STDS (2010) 1.06
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. Mol Med (2003) 1.06
Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol (2009) 1.05
Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis (2010) 1.05
HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05
Cytomegalovirus pneumonia in immunocompetent host: case report and literature review. J Clin Virol (2012) 1.03
Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis (2011) 1.01
Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients. J Infect (2006) 0.97
Genetic confirmation of quinine-resistant Plasmodium falciparum malaria followed by postmalaria neurological syndrome in a traveler from Mozambique. J Clin Microbiol (2004) 0.96
Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Am J Kidney Dis (2006) 0.96
Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011. BMC Infect Dis (2013) 0.95
Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol (2012) 0.94
The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism. J Biol Chem (2002) 0.93
Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal (2007) 0.93
Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2011) 0.93
Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care (2003) 0.92
Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerg Infect Dis (2013) 0.92
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection. Microb Drug Resist (2013) 0.92
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration. Ann Pharmacother (2010) 0.91
Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses (2012) 0.91
Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis (2003) 0.91
Criteria for discharge of patients with Ebola virus diseases in high-income countries. Lancet Glob Health (2015) 0.90
Role of previous hospitalization in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study. BMC Infect Dis (2007) 0.90
Methicillin-resistant Staphylococcus aureus: a community health threat. Postgrad Med (2010) 0.90
How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care (2014) 0.89
Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef. Proc Am Thorac Soc (2011) 0.89
Streptococcus salivarius meningitis and sphenoid sinus mucocele. Case report and literature review. J Infect (2005) 0.89
Hemolytic anemia due to acute cytomegalovirus infection in an immunocompetent adult: a case report and review of the literature. J Med Case Rep (2010) 0.88
Border screening for SARS. Med J Aust (2004) 0.88
Smoking and HIV: time for a change? BMC Med (2013) 0.87
Profile of infective endocarditis in a referral hospital over the last 24 years. J Infect (2006) 0.87
Clostridium difficile 027 infection in Central Italy. BMC Infect Dis (2012) 0.86
Human herpesvirus 8 and pulmonary hypertension. Emerg Infect Dis (2005) 0.85
Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century. Expert Rev Anti Infect Ther (2014) 0.85
Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes. J Surg Res (2008) 0.84
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother (2008) 0.84
Treatment and outcome of pulmonary arterial hypertension in HIV-infected patients: a review of the literature. Curr HIV Res (2009) 0.83
p47phox participates in activation of RelA in endothelial cells. J Biol Chem (2003) 0.83
Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort. J Acquir Immune Defic Syndr (2016) 0.82
Surgical site infections in plastic surgery: an italian multicenter study. J Surg Res (2007) 0.82
Fatal myocardial co-infection by Toxoplasma gondii and Parvovirus B19 in an HIV patient. AIDS (2007) 0.82
Acute hepatocellular and cholestatic injury during therapy with hydrochlorothiazide - clinicohistopathologic findings: a case report. J Med Case Rep (2010) 0.82
Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000. AIDS (2003) 0.82
Sildenafil plasma concentrations in two HIV patients with pulmonary hypertension treated with ritonavir-boosted protease inhibitors. Curr HIV Res (2012) 0.82
Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital. New Microbiol (2008) 0.81
Pulmonary hypertension in individuals with HIV infection. AIDS (2006) 0.81
QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording. BMC Cardiovasc Disord (2012) 0.81
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. J Antimicrob Chemother (2012) 0.80
A survey on infection management practices in Italian ICUs. Crit Care (2012) 0.80
Alterations in redox homeostasis and prostaglandins impair endothelial-dependent vasodilation in euglycemic autoimmune nonobese diabetic mice. Free Radic Biol Med (2005) 0.80
Particulate phase cigarette smoke increases MnSOD, NQO1, and CINC-1 in rat lungs. Free Radic Biol Med (2004) 0.80
HIV-1 Tat increases oxidant burden in the lungs of transgenic mice. Free Radic Biol Med (2011) 0.80
Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice. Cardiovasc Diagn Ther (2012) 0.79
Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: case report and literature review. AIDS (2006) 0.79
Salmonella enterica ssp. arizonae infection in a 43-year-old Italian man with hypoglobulinemia: a case report and review of the literature. J Med Case Rep (2011) 0.79
HIV infection and pulmonary arterial hypertension. Expert Rev Respir Med (2011) 0.79
Pulmonary arterial hypertension and HIV infection. AIDS (2008) 0.78
Clostridium difficile infection in the elderly. Infez Med (2013) 0.78
Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia. PLoS One (2011) 0.78
Telavancin and daptomycin activity against meticillin-resistant Staphylococcus aureus strains after vancomycin-resistance selection in vitro. J Med Microbiol (2013) 0.77
Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res (2011) 0.77